Ruxolitinib
DrugBank ID: DB08877
Summary
| Metric | Value |
|---|---|
| Total Predictions | 54 |
| KG+DL (Dual Validated) | 3 |
| DL Only | 47 |
| KG Only | 4 |
Predictions
| Indication | Score | Source |
|---|---|---|
| uterine corpus perivascular epithelioid cell tumor | 0.9973 | DL |
| benign PEComa | 0.9973 | DL |
| lymphangiomyoma | 0.9972 | DL |
| lymphangioleiomyomatosis | 0.9964 | DL |
| liposarcoma | 0.9952 | DL |
| familial rhabdoid tumor | 0.9949 | DL |
| lung PEComa | 0.9944 | DL |
| ovarian myxoid liposarcoma | 0.9939 | DL |
| primary myelofibrosis | 0.9935 | KG+DL |
| acquired hemophagocytic lymphohistiocytosis associated with malignant disease | 0.9932 | DL |
| hemophagocytic syndrome associated with an infection | 0.9932 | DL |
| thrombocytopenia | 0.9930 | DL |
| dermatofibrosarcoma protuberans | 0.9929 | DL |
| plasmacytoma | 0.9922 | KG+DL |
| hereditary thrombocytopenia with normal platelets | 0.9915 | DL |
| marcothrombocytopenia with mitral valve insufficiency | 0.9914 | DL |
| transient neonatal thrombocytopenia | 0.9912 | DL |
| dense granule disease | 0.9908 | DL |
| neurolymphomatosis | 0.9886 | DL |
| rhabdoid tumor | 0.9866 | DL |
| heart fibrosarcoma | 0.9865 | DL |
| fibroblastic neoplasm | 0.9865 | DL |
| kidney fibrosarcoma | 0.9864 | DL |
| vulva sarcoma | 0.9863 | DL |
| conventional fibrosarcoma | 0.9862 | DL |
| low grade fibromyxoid sarcoma | 0.9855 | DL |
| relapsing-remitting multiple sclerosis | 0.9824 | DL |
| Budd-Chiari syndrome | 0.9819 | DL |
| liver fibrosarcoma | 0.9808 | DL |
| spindle cell liposarcoma | 0.9808 | DL |
| familial generalized lentiginosis | 0.9802 | DL |
| hepatic vein thrombosis | 0.9795 | DL |
| bone fibrosarcoma | 0.9794 | DL |
| myeloproliferative neoplasm | 0.9789 | KG+DL |
| leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome | 0.9782 | DL |
| non-syndromic syndactyly | 0.9779 | DL |
| acromelanosis | 0.9779 | DL |
| congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome | 0.9779 | DL |
| myeloproliferative neoplasm, unclassifiable | 0.9777 | DL |
| peripheral nerve schwannoma | 0.9777 | DL |
| chronic neutrophilic leukemia | 0.9762 | DL |
| hemophagocytic syndrome | 0.9759 | DL |
| sympathetic neurilemmoma | 0.9755 | DL |
| schwannoma of twelfth cranial nerve | 0.9754 | DL |
| Dedifferentiated liposarcoma | 0.9751 | DL |
| microcystic/reticular schwannoma | 0.9745 | DL |
| trigeminal schwannoma | 0.9745 | DL |
| gastrocutaneous syndrome | 0.9744 | DL |
| Moynahan syndrome | 0.9743 | DL |
| atypical lipomatous tumor | 0.9739 | DL |
Showing top 50 of 54 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.